Early fallopian tube cell changes were found in a high‑risk patient. A live tissue bank and organoid system will help explore ...

Long-term results from the phase 2 OVARIO trial (NCT03326193) highlight the effectiveness of niraparib plus bevacizumab as maintenance therapy in patients with advanced ovarian cancer.

The disease affects roughly 10 per cent of women and girls of reproductive age globally, according to the World Health ...

A woman who was in the best shape of her life before being diagnosed with a 'rare' form of cancer has spoken out about her ...

Eggs and embryos from people with polycystic ovary syndrome have altered patterns of so-called epigenetic tags, which could ...

Genetic testing revealed that she was positive for BRCA1, a genetic mutation that increases one’s risk of breast and ovarian ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...

Polycystic ovary syndrome is so fundamentally misunderstood, patients, researchers and medical professionals the world over are trying to change its name, with the effort led by Australian medical ...

This new article publication from Acta Pharmaceutica Sinica B, discusses how a psychological stress-activated NR3C1/NUPR1 axis promotes ovarian tumor metastasis.

New findings connect polycystic ovary syndrome (PCOS) with gut microbiota imbalance and metabolic disruptions impacting ...

US ovarian cancer mortality rates declined from 1999 to 2020, but significant disparities remain across age, race, and geographic regions, highlighting the need for targeted public health efforts.